RU1451915C - Method of matricary essential oil stabilization - Google Patents

Method of matricary essential oil stabilization Download PDF

Info

Publication number
RU1451915C
RU1451915C SU4247583A RU1451915C RU 1451915 C RU1451915 C RU 1451915C SU 4247583 A SU4247583 A SU 4247583A RU 1451915 C RU1451915 C RU 1451915C
Authority
RU
Russia
Prior art keywords
essential oil
matricary
oil stabilization
stabilization
ratio
Prior art date
Application number
Other languages
Russian (ru)
Inventor
О.А. Коновалова
К.С. Рыбалко
Н.С. Михайлова
В.С. Кабанов
С.Я. Соколов
А.И. Багинская
Т.Е. Лескова
Т.И. Городнюк
Л.Ф. Белова
Н.Н. Маргвелашвили
Р.Г. Мартынова
Original Assignee
Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений" filed Critical Научно-производственное объединение "Всероссийский научно-исследовательский институт лекарственных и ароматических растений"
Priority to SU4247583 priority Critical patent/RU1451915C/en
Application granted granted Critical
Publication of RU1451915C publication Critical patent/RU1451915C/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

FIELD: chemical-pharmaceutical industry. SUBSTANCE: castor oil is added to the matricary essential oil at the ratio 1:(0.8-1). EFFECT: increased storage of product.

Description

Изобретение относится к фармацевтической промышленности и касается способов стабилизации лекарственных средств. The invention relates to the pharmaceutical industry and relates to methods for stabilizing drugs.

Целью изобретения является увеличение срока хранения. The aim of the invention is to increase the shelf life.

Способ поясняется следующим примером. 50 г эфирного масла ромашки аптечной смешивают с 50 г медицинского касторового масла. Содержание хамазулена в смеси 3,1%. После хранения в течение 4 лет содержание хамазулена составляет 3% . Срок хранения стабилизированного эфирного масла, полученного по известному способу, 1 год. The method is illustrated by the following example. 50 g of essential oil of chamomile pharmacy is mixed with 50 g of medical castor oil. The content of chamazulene in the mixture is 3.1%. After storage for 4 years, the content of chamazulene is 3%. The shelf life of the stabilized essential oil obtained by a known method, 1 year.

Claims (1)

СПОСОБ СТАБИЛИЗАЦИИ ЭФИРНОГО МАСЛА РОМАШКИ АПТЕЧНОЙ путем добавления стабилизатора, отличающийся тем, что, с целью увеличения срока хранения, в качестве стабилизатора используют касторовое масло в соотношении 1 : (0,8 - 1). METHOD FOR STABILIZING ESSENTIAL OIL OF CHAMMER'S PHARMACY by adding a stabilizer, characterized in that, in order to increase the shelf life, castor oil is used as stabilizer in a ratio of 1: (0.8 - 1).
SU4247583 1987-05-21 1987-05-21 Method of matricary essential oil stabilization RU1451915C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4247583 RU1451915C (en) 1987-05-21 1987-05-21 Method of matricary essential oil stabilization

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4247583 RU1451915C (en) 1987-05-21 1987-05-21 Method of matricary essential oil stabilization

Publications (1)

Publication Number Publication Date
RU1451915C true RU1451915C (en) 1994-10-15

Family

ID=30440687

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4247583 RU1451915C (en) 1987-05-21 1987-05-21 Method of matricary essential oil stabilization

Country Status (1)

Country Link
RU (1) RU1451915C (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Авторское свидетельство СССР N 1116723, кл. A 61K 35/78, 1983. *

Similar Documents

Publication Publication Date Title
AU604061B2 (en) Drug compositions stabilized against oxidation
FI87524C (en) Process for preparing a stabilized tocopherol composition in free liquid particulate form
US3975519A (en) Method for increasing the oxygen partial pressure in the bloodstream of mammals
CA1297023C (en) Stabilized drug composition containing ascorbic acid
HU226117B1 (en) Stable liquid paracetamol compositions
KR850000975A (en) Compositions based on mixtures of valproic acid and salts thereof
FR2442054A1 (en) PURIFIED PROTEINS, IN PARTICULAR INTERFERON, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2469178A1 (en) AQUEOUS NITROGLYCERIN SOLUTION AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME
RU95111308A (en) Derivatives of 2-amino-4-phenyl-4-oxobutyric acid, methods of synthesis, pharmaceutical composition
EA014673B1 (en) Aqueous anaesthetic compositions comprising propofol
KR900017586A (en) Ketanserine derivatives
US5104896A (en) Carboplatin composition
RU1451915C (en) Method of matricary essential oil stabilization
US3230143A (en) Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4289783A (en) Etomidate-containing compositions
HUP9603489A2 (en) Medical composition and process for producing it
EP0159735A1 (en) Pharmaceutical composition containing tetracyclin or doxycyclin salts and a process of preparing such a composition
US4141975A (en) Equine parasiticide paste
US3777019A (en) Stabilized chlorpromazine hydrochlo-ride solution for use in disposable cartridges
US5447720A (en) Composition and method for treatment of hemoglobinopathies
US2835627A (en) Stable vitamin b12 solutions
JPH06199694A (en) Agent for stabilizing blood pressure
JPS5726587A (en) Stabilization of ascorbic acid oxidase
CA2085142A1 (en) Stabilized pharmaceutical composition of non glycosyled recombinant human il2 in reduced form and preparation process therefore
EP0331948B1 (en) Pharmaceutical composition for the transdermal administration of heparin